Emerald Hills, California
United States
17
2023-03-02
The entities that hold a legal rights for patent applications filed by inventor Stefanich Eric Gary:
Eric Gary Stefanich from Emerald Hills, US has applied for patents for these inventions. The list has both pending applications and granted patents:
IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#2 | 2022-11-03USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#3 | 2019-10-10USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#4 | 2019-08-01IL-22 Fc fusion proteins
#5 | 2019-06-13Methods for treating metabolic syndrome using IL-22 Fc fusion proteins
#6 | 2019-06-13Methods of treating acute pancreatitis using IL-22 fc fusion proteins
#7 | 2019-06-13Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins
#8 | 2019-06-13IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#9 | 2019-06-13IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE
#10 | 2018-12-20Pharmaceutical compositions of IL-22 Fc fusion proteins
#11 | 2018-12-13IL-22 Fc FUSION PROTEIN AND METHODS OF USE
#12 | 2017-11-09Methods of accelerating or improving wound healing using IL-22 FC fusion proteins
#13 | 2017-04-13USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#14 | 2017-03-30Nucleic acids encoding IL-22 Fc fusion proteins
#15 | 2017-01-12IL-22 Fc fusion proteins
#16 | 2014-10-23Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins
#17 | 2013-05-02USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
222924 ⎘